We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00435006
First Posted: February 14, 2007
Last Update Posted: February 14, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University of Copenhagen
Novo Nordisk A/S
AP Moeller Foundation
Information provided by:
Rigshospitalet, Denmark
February 13, 2007
February 14, 2007
February 14, 2007
August 2003
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages
Not Provided
The purpose of this study is to assess the prevalence and predictors of pituitary dysfunction, as well as secondary out-come in patients with traumatic brain injury or spontaneous subarachnoidal haemorrhages.
Not Provided
Observational
Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Retrospective/Prospective
Not Provided
Not Provided
Not Provided
Not Provided
  • Brain Injuries
  • Intracranial Aneurysm
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
June 2006
Not Provided

Inclusion Criteria:

  • Clinical diagnosis of traumatic brain injury (TBI) or subarachnoidal haemorrhages (SAH)

Exclusion Criteria:

  • Alcohol or drug abuse
  • Prior TBI or SAH
  • Chronic use of glucocorticoids
  • Pregnancy or breast feeding
  • Diagnosis of psychiatric diseases or malignant neoplasms
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
Not Provided
Contact information is only displayed when the study is recruiting subjects
Denmark
 
 
NCT00435006
KF-01-107/03
Not Provided
Not Provided
Not Provided
Not Provided
Rigshospitalet, Denmark
  • University of Copenhagen
  • Novo Nordisk A/S
  • AP Moeller Foundation
Principal Investigator: Marianne C Klose, MD Dept. of Endocrinology PE2131, Copenhagen University Hospital, Rigshospitalet
Rigshospitalet, Denmark
February 2007